| Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls | Oncogene | 2006 | 80 |
| Solifenacin significantly improves all symptoms of overactive bladder syndrome | International Journal of Clinical Practice | 2006 | 77 |
| Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: A critical analysis of results | European Urology | 2006 | 71 |
| Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma | Journal of Pathology | 2006 | 66 |
| Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study | European Urology | 2006 | 53 |
| Characteristics of patients presenting with LUTS/BPH in six European countries | European Urology | 2006 | 45 |
| Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome | International Journal of Urology | 2006 | 44 |
| Effect of an ATP-sensitive potassium channel opener in subjects with overactive bladder: a randomized, double-blind, placebo-controlled study (ZD0947IL/0004) | European Urology | 2006 | 41 |
| Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism | Journal of Developmental and Physical Disabilities | 2006 | 39 |
| Sleep exacerbation of persistent sexual arousal syndrome in a postmenopausal woman | Journal of Sexual Medicine | 2006 | 32 |
| Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder | Autonomic and Autacoid Pharmacology | 2006 | 31 |
| The Impact of Nocturia in Patients with LUTS/BPH: Need for New Recommendations | European Urology Supplements | 2006 | 21 |
| Benign prostatic hyperplasia: treatment in primary care | BMJ, The | 2006 | 19 |
| Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle | European Urology | 2006 | 15 |
| Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder | Expert Opinion on Pharmacotherapy | 2006 | 15 |
| Minimally invasive nephron-sparing surgery for renal cell cancer | BJU International | 2006 | 15 |
| The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity | International Journal of Clinical Practice | 2006 | 7 |
| Botulinum toxin in urinary incontinence | Current Opinion in Urology | 2006 | 5 |
| Botulinum toxin injection therapy in the management of lower urinary tract dysfunction | International Journal of Clinical Practice | 2006 | 5 |
| A model of the natural history of screen-detected prostate cancer | British Journal of Cancer | 2006 | 3 |
| The Need for Improved Therapeutic Strategies for Patients with Metastatic Hormone-Refractory Prostate Cancer | European Urology Supplements | 2006 | 3 |
| The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care? | Journal of Molecular Medicine | 2006 | 2 |
| Alpha antagonists-from initial concept to routine clinical practice | European Urology | 2006 | 2 |
| Acute urinary retention: who is at risk and how best to manage it? | Current Urology Reports | 2006 | 1 |
| Acute urinary retention: Who is at risk and how best to manage it? | Current Prostate Reports | 2006 | |
